Meetings with the pharmaceutical industry since December 1st 2019

Die Antwort auf diese Anfrage ist lange im Rückstand. Nach gesetzlicher Vorschrift sollte Internal Market, Industry, Entrepreneurship and SMEs Ihnen inzwischen unter allen Umständen geantwortet haben. (Details). Sie können sich beschweren, indem sie Interne Prüfung beantragen .

Dear Internal Market, Industry, Entrepreneurship and SMEs,

On behalf of Corporate Europe Observatory (CEO), I would like to - under the right of access to documents in the EU treaties as developed in Regulation 1049/2001 - request access to the following documents:

- all reports (and other notes) from meetings between DG GROW and representatives of the pharmaceutical industry (companies as well as organisations such as EFPIA) from December 1st 2019 onwards. This should include the following companies: Bayer AG, Novartis International AG, Merck, GlaxoSmithKline, Amgen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, SANOFI, Pfizer Inc., AstraZeneca, Eli Lilly and Company, and MSD (Europe) Inc. (Merck Sharp & Dohme).

- all correspondence (including emails) between the DG GROW and representatives of the pharmaceutical industry (companies as well as organisations such as EFPIA) from December 1st 2019 onwards.

- a list of all the above-mentioned documents (including dates, names of participants/senders/recipients and their affiliation, subject of meeting/correspondence)

Yours faithfully,
Olivier Hoedeman

on behalf of Corporate Europe Observatory (CEO)
Corporate Europe Observatory (CEO)
Rue d'Edimbourg 26,
1050 Brussels, Belgium

http://www.corporateeurope.org
Tel. +32 (0)2 893 0930
Mobile: +32 474 486545
EU Transparency Register ID Number: 5353162366-85

Internal Market, Industry, Entrepreneurship and SMEs

1 Attachment

Dear Mr Hoedeman,

 

Thank you for your e-mail dated 14/01/2020.  We hereby acknowledge receipt
of your application for access to documents, which was registered on
16/01/2020 under reference number GestDem 2020/0311.

 

In accordance with Regulation (EC) No 1049/2001 regarding public access to
European Parliament, Council and Commission documents, your application
will be handled within 15 working days. The time limit will expire on
06/02/2020. In case this time limit needs to be extended, you will be
informed in due course.

 

You have lodged your application via the AsktheEU.org website. Please note
that this is a private website which has no link with any institution of
the European Union. Therefore the European Commission cannot be held
accountable for any technical issues or problems linked to the use of this
system.

 

Please note also that the European Commission is not responsible for any
possible processing of personal data by the private organisation running
the AsktheEU.org website, through which you have channelled your request.
Please refer to their privacy policy.

 

Yours sincerely, 

 

DG GROW – Access to documents team

 

[1]cid:479385507@17082012-2045

European Commission
Directorate-General for Internal Market, Industry, Entrepreneurship and
SMEs
DG  GROW/01 – Coordination and Planning

 

 

References

Visible links

Internal Market, Industry, Entrepreneurship and SMEs

1 Attachment

Dear Mr Hoedeman,

 

We refer to your e-mail dated 14/01/2020 in which you make a request for
access to documents, registered on 16/01/2020 under the above mentioned
reference number.

Your application is currently being handled. However, we will not be in a
position to complete the handling of your application within the time
limit of 15 working days, which expires today.

 

Therefore, we have to extend the time limit with 15 working days in
accordance with Article 7(3) of Regulation (EC) No 1049/2001 regarding
public access to documents. The new time limit expires on 27/02/2020.

 

We apologize for this delay and for any inconvenience this may cause.

 

Yours sincerely,

 

DG GROW – Access to documents team

European Commission
Directorate-General for Internal Market, Industry, Entrepreneurship and
SMEs
DG GROW/01 – Coordination and Planning